Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein

Autor:	Wang, Yu, Ding, Xiwei, Wang, Shaoqing, Moser, Catherine D., Shaleh, Hassan M., Mohamed, Essa A., Chaiteerakij, Roongruedee, Allotey, Loretta K., Chen, Gang, Miyabe, Katsuyuki, McNulty, Melissa S., Ndzengue, Albert, Barr Fritcher, Emily G., Knudson, Ryan A., Greipp, Patricia T., Clark, Karl J., Torbenson, Michael S., Kipp, Benjamin R., Zhou, Jie, Barrett, Michael T., Gustafson, Michael P., Alberts, Steven R., Borad, Mitesh J., Roberts, Lewis R. *
Zdroj:	In Cancer Letters 28 September 2016 380(1):163-173
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect